Bank Of New York Mellon Corp Cytokinetics Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$33.36 - $45.71 $42.8 Million - $58.7 Million	1,283,092 New	1,283,092 $45.2 Billion
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $47.3 Million - $67.6 Million	1,323,456 New	1,323,456 $60.6 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $9.09 Million - $12.9 Million	235,823 Added 20.74%	1,372,769 $66.5 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $10.1 Million - $14.5 Million	296,254 Added 35.24%	1,136,946 $44.7 Million
Q1 2022 May 11, 2022	SELL	$29.74 - $46.0 $1.2 Million - $1.86 Million	-40,478 Reduced 4.59%	840,692 $30.9 Million
Q4 2021 Feb 11, 2022	BUY	$34.35 - $46.38 $3.04 Million - $4.11 Million	88,629 Added 11.18%	881,170 $40.2 Million
Q3 2021 Nov 12, 2021	BUY	$18.54 - $35.74 $3.15 Million - $6.07 Million	169,955 Added 27.3%	792,541 $28.3 Million
Q2 2021 Aug 11, 2021	SELL	$19.79 - $26.99 $1.28 Million - $1.74 Million	-64,576 Reduced 9.4%	622,586 $12.3 Million
Q1 2021 May 13, 2021	SELL	$18.57 - $25.68 $2,785 - $3,852	-150 Reduced 0.02%	687,162 $16 Million
Q4 2020 Feb 09, 2021	SELL	$15.26 - $28.61 $294,609 - $552,344	-19,306 Reduced 2.73%	687,312 $14.3 Million
Q3 2020 Nov 12, 2020	BUY	$20.58 - $28.96 $1.03 Million - $1.45 Million	49,901 Added 7.6%	706,618 $15.3 Million
Q2 2020 Aug 12, 2020	BUY	$11.15 - $24.64 $437,013 - $965,740	39,194 Added 6.35%	656,717 $15.5 Million
Q1 2020 May 06, 2020	SELL	$8.75 - $16.3 $196,656 - $366,342	-22,475 Reduced 3.51%	617,523 $7.28 Million
Q4 2019 Feb 14, 2020	BUY	$7.95 - $11.84 $36,713 - $54,677	4,618 Added 0.73%	639,998 $6.79 Million
Q3 2019 Nov 07, 2019	SELL	$10.82 - $14.25 $76,172 - $100,320	-7,040 Reduced 1.1%	635,380 $7.23 Million
Q2 2019 Aug 12, 2019	BUY	$7.95 - $11.25 $376,345 - $532,563	47,339 Added 7.96%	642,420 $7.23 Million
Q1 2019 May 14, 2019	BUY	$5.95 - $10.19 $20,658 - $35,379	3,472 Added 0.59%	595,081 $4.81 Million
Q4 2018 Feb 11, 2019	BUY	$5.91 - $9.29 $59,951 - $94,237	10,144 Added 1.74%	591,609 $3.74 Million
Q3 2018 Nov 09, 2018	BUY	$6.4 - $9.85 $191,507 - $294,741	29,923 Added 5.43%	581,465 $0
Q2 2018 Aug 06, 2018	SELL	$6.9 - $9.9 $51,198 - $73,458	-7,420 Reduced 1.33%	551,542 $4.58 Million
Q1 2018 May 15, 2018	BUY	$7.2 - $10.05 $137,800 - $192,346	19,139 Added 3.55%	558,962 $4.02 Million
Q4 2017 Feb 09, 2018	BUY	$7.25 - $15.65 $3.91 Million - $8.45 Million	539,823	539,823 $4.4 Million

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

Black Rock Inc. New York, NY

14.7M
Shares

$732 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$586 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

9.69M
Shares

$483 Million
0.31% of portfolio
Wellington Management Group LLP Boston, MA

7.77M
Shares

$388 Million
0.07% of portfolio
State Street Corp Boston, MA

6.46M
Shares

$322 Million
0.01% of portfolio

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.69B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account